AXON

Axon Enterprise

$612.83

-0.45%
Aug 14, 2026
Bobby Quantitative Model
Axon Enterprise, Inc. is a public safety technology company that designs, manufactures, and sells a suite of hardware devices and cloud software solutions, including TASER energy weapons, body cameras, digital evidence management, and drone/counter-drone technologies. As a market leader in the law enforcement technology space, Axon has established a dominant position with its integrated hardware-software ecosystem, often compared to a 'public safety operating system.' The current investor narrative centers on the company's explosive growth in AI-driven products and drone demand, which drove a strong Q1 2026 earnings beat and raised guidance, yet the stock remains over 50% below its 52-week high, creating a debate about whether the market is mispricing its long-term potential or if the high valuation and competitive risks justify the decline.

People also watch

SpaceX

SpaceX

SPCX

Analysis
GE Aerospace

GE Aerospace

GE

Analysis
RTX

RTX

RTX

Analysis
Boeing

Boeing

BA

Analysis
Lockheed Martin

Lockheed Martin

LMT

Analysis

BobbyInvestment Opinion: Should I buy AXON Today?

We rate AXON as a 'Buy' with a thesis that its dominant position in public safety technology, combined with explosive AI and drone demand, justifies the high valuation. The analyst consensus is 'Buy' with an average target of $660.88, implying 26.5% upside from the current price of $522.46. The company's revenue growth of 33.75% YoY and improving margins support this view, despite the elevated PE ratios.

Sign up to view all

AXON 12-Month Price Forecast

The AI-driven growth narrative is compelling, with Axon's revenue acceleration and product innovation positioning it well in the public safety tech market. However, the high valuation and operational inefficiencies warrant caution. I would upgrade to 'high' confidence if the company demonstrates sustained operating margin improvement and revenue growth above 35% in the next two quarters. Conversely, a downgrade to 'neutral' would occur if growth decelerates or margins deteriorate.

Historical Price
Current Price $612.83
Average Target $591.00
High Target $825.00
Low Target $339.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Axon Enterprise's 12-month outlook, with a consensus price target around $693.40 and implied upside of +13.2% versus the current price.

Average Target

$693.40

0 analysts

Implied Upside

+13.2%

vs. current price

Analyst Count

covering this stock

Price Range

$410 - $830

Analyst target range

The target price range spans from a low of $409.68 to a high of $825.00, representing a potential downside of -21.6% and an upside of 57.9% from the current price. The high target likely assumes that Axon's AI and drone initiatives will drive accelerated growth and margin expansion, while the low target may reflect concerns about competitive pressures, regulatory issues, or a slowdown in law enforcement spending. The wide spread of $415.32 between the low and high targets signals high uncertainty about the company's future performance. Recent institutional ratings have been predominantly positive, with no downgrades in the last three months, indicating that analysts are maintaining their bullish stance despite the stock's volatility. This suggests that the market's current valuation may be overly pessimistic relative to the analyst community's expectations.

Drowning in data?

Find the real signal!

Bulls vs Bears: AXON Investment Factors

Axon presents a compelling growth story with accelerating revenue, strong analyst support, and a dominant market position, but it is marred by extreme valuation, high volatility, and operational inefficiencies. The bull case is stronger in the long term, driven by AI and drone demand, but the bear case highlights near-term risks of valuation compression and market sentiment. The key tension is whether the market's current pessimism (stock down 50% from highs) is an overreaction to short-term noise or a rational response to unsustainable growth expectations. If Axon can sustain 30%+ revenue growth and improve margins, the stock could re-rate higher; otherwise, it risks further downside.

Bullish

  • Explosive Revenue Growth: Q1 2026 revenue surged 33.75% YoY to $807.3M, up from $603.6M in Q1 2025, with sequential growth from $796.7M in Q4 2025. This acceleration is driven by AI and drone products, indicating strong market demand.
  • AI and Drone Demand Catalyst: Recent news highlights explosive AI and drone demand, with analysts suggesting revenue could triple by 2028. The company's innovative product pipeline positions it to capitalize on the AI boom in public safety.
  • Strong Analyst Support: With 19 analysts, the consensus rating is 'Buy' (mean 1.71) and the average target price is $660.88, implying 26.5% upside from $522.46. No downgrades in the last three months signal sustained confidence.
  • Margin Expansion Potential: Q1 2026 gross margin improved to 59.1% from 57.9% in Q4 2025, and net margin jumped to 21.0% from 0.4% in Q4 2025. This demonstrates operating leverage and profitability scaling.

Bearish

  • Extreme Valuation Risk: Trailing PE is 354.96x and forward PE is 49.42x, far above industry averages. Even with strong growth, the stock is priced for perfection, leaving little room for error.
  • Stock Down 50% from Highs: The stock trades at $522.46, 41% below its 52-week high of $885, with a 1-year price change of -39.51% vs. S&P 500 +21.46%. This underperformance suggests waning investor confidence despite fundamentals.
  • High Volatility and Beta: With a beta of 1.397 and a max drawdown of -60.28%, the stock is highly volatile. Recent 1-month change of -18.42% shows sharp swings, making it risky for short-term investors.
  • Negative Operating Margin: Despite strong revenue growth, operating margin was -2.23% in the latest quarter, indicating that core operations are not yet profitable. This raises concerns about cost control and scalability.

AXON Technical Analysis

Axon's stock is in a pronounced downtrend over the past year, with a 1-year price change of -39.51%, significantly underperforming the S&P 500's +21.46% gain. The current price of $522.46 sits at approximately 59% of its 52-week range (between a low of $339.01 and a high of $885.00), indicating the stock is closer to its lows than its highs, which often suggests either a value opportunity or a falling knife. The 52-week high of $885 was reached in early 2026, and the stock has since retraced substantially, reflecting a loss of investor confidence despite strong fundamentals.

Beta

1.40

1.40x market volatility

Max Drawdown

-60.3%

Largest decline past year

52-Week Range

$339-$794

Price range past year

Annual Return

-18.3%

Cumulative gain past year

PeriodAXON ReturnS&P 500
1m+13.3%+2.9%
3m+56.4%+5.0%
6m+42.6%+13.9%
1y-18.3%+20.4%
ytd+8.8%+13.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

AXON Fundamental Analysis

Axon's revenue growth is accelerating, with Q1 2026 revenue of $807.3 million, up 33.75% year-over-year, and a sequential increase from $796.7 million in Q4 2025. The company's revenue trajectory has been consistently strong, with quarterly revenue growing from $503.2 million in Q2 2024 to $807.3 million in Q1 2026, a 60% increase over that period. The growth is driven by both the Connected Devices segment (TASER, body cameras) and the Software and Services segment, with recent demand for AI and drone products adding a new growth vector. This robust growth supports the investment case, but the sustainability of such high growth rates is a key question.

Quarterly Revenue

$807345000.0B

2026-03

Revenue YoY Growth

+33.8%

YoY Comparison

Gross Margin

59.1%

Latest Quarter

Free Cash Flow

$19507000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Axon Body
Platform Solutions
Software And Sensors Segment
TASER X2

Open an Account, get $2 TSLA now!

Valuation Analysis: Is AXON Overvalued?

Given that Axon's trailing net income is positive (e.g., $169.3 million in Q1 2026), the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 354.96x, while the forward PE is 49.42x, indicating that the market expects significant earnings growth in the next year. The wide gap between trailing and forward PE suggests the market is pricing in a substantial improvement in profitability, which is consistent with the company's recent margin expansion and raised guidance. The forward PE of 49.42x is still high, implying that the market expects continued strong growth to justify the valuation.

PE

355.0x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 32x~170x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

236.1x

Enterprise Value Multiple

Investment Risk Disclosure

Financial risks are significant, with a trailing PE of 354.96x and forward PE of 49.42x, indicating that the market expects massive earnings growth. The company's debt-to-equity ratio of 0.59 is manageable, but its negative operating margin of -2.23% in Q1 2026 suggests that core operations are not yet profitable, relying on interest income and tax benefits for net income. Free cash flow is minimal at $19.5M TTM, limiting financial flexibility. Revenue concentration in the Connected Devices segment, which generates the majority of sales, exposes the company to hardware cyclicality and potential supply chain disruptions.